• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a new therapeutic method for familial amyloid polyneuropathy

Research Project

Project/Area Number 18590932
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionShinshu University

Principal Investigator

SEKIJIMA Yoshiki  Shinshu University, Hospital, Associate Professor (60322715)

Co-Investigator(Kenkyū-buntansha) YAZAKI Masahide  Shinshu University, Hospital, Senior Assistant Professor (70372513)
Project Period (FY) 2006 – 2007
Project Status Completed (Fiscal Year 2007)
Budget Amount *help
¥3,890,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥390,000)
Fiscal Year 2007: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2006: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsProtein / Neurolopical Diseases / Neuroscience / Pharmacology / Gene / Amyloid / Misfolding / Transthvretin / タンパク質 / 遺伝子
Research Abstract

Transthyretin (TTR) tetramer dissociation, misfolding and misassembly are required for the process of amyloid fibril formation associated with familial amyloid polyneurcpathy (FAP). Preferential stabilization of the native 'nit tetramer over the dissociative transition state by small molecule binding raises the kinetic barrier of tetramer dissociation, preventing amyloidogenesis. First of all, we screened already approved drugs, and found that two NSAIDs, diflunisal and flufenamic add, stsbilize the native nu tetramer stracture and strongly inhibit TTR amyoidd fibril formation in vitro Next, we investigated the feasibility of using these molecules for the treatment of FAP utilizing serum samples from 37 FAP patients with 10 different mutations. We demonstrated that the TTR heterotetramer structures in FAP patients serum are significantly less stable than that in normal subjects, indicating the instability of the variant lilt structure is a fundamental cause of TTR amyloidosis. We also demonstrated that therapeutic serum concentrations of diflunisal stabilized serum variant TTR tetramer better than those of flufenamic acid. Importantly, diflunisal increased serum TTR. stability in FAP patients beyond the level of normal controls, indicating that diflunisal could be as effective as liver transplantation, which has proven to be an effective therapeutic strategy Based on these findings, we analyzed the effects of orally administered diflunisal on the serum Tilt tetramer stability in 15 FAP patients (phase II clinical trial). Orally administered diflunical significantly increased serum TM stability in FAP patients against add denaturation without side effects. To evaluate precise clinical effects of diflunisal, placebo-control double blind clinical trial is now enrolling patients internationally.

Report

(3 results)
  • 2007 Annual Research Report   Final Research Report Summary
  • 2006 Annual Research Report
  • Research Products

    (26 results)

All 2007 2006

All Journal Article (16 results) (of which Peer Reviewed: 3 results) Presentation (10 results)

  • [Journal Article] トランスサイレチンアミロイドーシスの発症メカニズムと治療戦略.2007

    • Author(s)
      関島良樹
    • Journal Title

      細胞工学 26

      Pages: 162-167

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] アミロイドーシス発症の分子機構解明を目指して-現状と展望,夢-2007

    • Author(s)
      後藤祐児, 桑田一夫, 関島良樹, 田中元雅, 内木宏延, 永井義隆, 松崎勝巳, 樋口京一
    • Journal Title

      細胞工学 26

      Pages: 181-185

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Pathogenesis and therapeutic strategy for transthyretin amyloidosis2007

    • Author(s)
      Sekiiima, Y
    • Journal Title

      Cell Technology 26

      Pages: 162-167

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Toward Understanding The Molecular Basis of Amyloidosis : Present and Future2007

    • Author(s)
      Goto, Y., Kuwata, K., Sekiiima, Y., Tanaka, M., Naiki, H., Nagai, Y., Matsuzaki, K., Higuchi, K
    • Journal Title

      Cell Technology 26

      Pages: 181-185

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] トランスサイレチンアミロイドーシスの発症メカニズムと治療戦略2007

    • Author(s)
      関島良樹
    • Journal Title

      細胞工学 26

      Pages: 162-167

    • Related Report
      2007 Annual Research Report
  • [Journal Article] アミロイドーシス発症の分子機構解明を目指して-現状と展望、夢-2007

    • Author(s)
      後藤裕児、桑田一夫、関島良樹、田中元雅、内木宏廷、永井義隆、松崎勝己、樋口京一
    • Journal Title

      細胞工学 26

      Pages: 181-185

    • Related Report
      2007 Annual Research Report
  • [Journal Article] トランスサイレンチンアミロイドーシスの発症メカニズムと治療戦略2007

    • Author(s)
      関島良樹
    • Journal Title

      細胞工学 26

      Pages: 162-167

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis2006

    • Author(s)
      Tojo K, Sekijima Y (correspondingauthor), Kelly JW, Ikeda S
    • Journal Title

      Neuroscience Research 56

      Pages: 441-449

    • NAID

      10019273683

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119M trans-suppression2006

    • Author(s)
      Sekijima Y, Dendle MT, Wiseman LR, White JT, D'Haeze W, Kelly JW
    • Journal Title

      Amyloid 13

      Pages: 67-66

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis2006

    • Author(s)
      Sekijima Y, Dendle MT, Kelly JW
    • Journal Title

      Amyloid 13

      Pages: 236-249

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis2006

    • Author(s)
      Tojo, K., Sekiiima, Y.(correonding author), Kelly, JW., Ikeda, S
    • Journal Title

      Neuroscience Research 56

      Pages: 441-449

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119M trans-suppression2006

    • Author(s)
      Sekiiima, Y., Dendle, MT., Wiseman, LR., White, JT., D'Haeze, W., Kelly, JW
    • Journal Title

      Amyloid 13

      Pages: 57-66

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis2006

    • Author(s)
      Sekiiima, Y., Dendle, MT., Kelly, JW
    • Journal Title

      Amyloid 13

      Pages: 236-249

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.2006

    • Author(s)
      Tojo K, Sekijima Y, Kelly JW, Ikeda S.
    • Journal Title

      Neuroscience Research 56・4

      Pages: 441-449

    • NAID

      10019273683

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.2006

    • Author(s)
      Sekijima Y, Dendle MT, Kelly JW.
    • Journal Title

      Amyloid 13・4

      Pages: 236-249

    • Related Report
      2006 Annual Research Report
  • [Journal Article] R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119M trans-suppression.2006

    • Author(s)
      Sekijima Y, Dendle MT, Wiseman LR, White JT, Haeze W, Kelly JW.
    • Journal Title

      Amyloid 13・2

      Pages: 57-66

    • Related Report
      2006 Annual Research Report
  • [Presentation] FAP患者に対するDiflunisalを用いた新たな薬物療法の開発2007

    • Author(s)
      関島良樹, 東城加奈, 池田修一
    • Organizer
      第48回日本神経学会総会
    • Place of Presentation
      名古屋,名古屋国際会議場
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Annual Research Report 2007 Final Research Report Summary
  • [Presentation] 集積地に認められたV30M TTRホモ接合体FAP家系の臨床的,生化学的検討2007

    • Author(s)
      東城加奈, 関島良樹, 池田修一
    • Organizer
      第48回日本神経学会総会
    • Place of Presentation
      名古屋,名古屋国際会議場
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Annual Research Report 2007 Final Research Report Summary
  • [Presentation] Develcpment of a new therapeutic method for familial amyloid polyneurapathy patients2007

    • Author(s)
      Sekiiima, Y., Tojo, K., Ikeda, S
    • Organizer
      The 48th Annual Meeting of the Japanese Society of Neurology
    • Place of Presentation
      Nagoya
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Clinical and biochemical analysis of a ATTR Va130Met homozygous family in an endemic area2007

    • Author(s)
      Tojo, K., Sekiiima Y., Kelly, JW., Ikeda, S
    • Organizer
      The 48th Annual Meeting of the Japanese Society of Neurology
    • Place of Presentation
      Nagoya
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] TTR四量体を安定化する低分子化合物を用いたFAPに対する薬物療法の開発2006

    • Author(s)
      関島良樹, 東城加奈, Kelly JW, 池田修一
    • Organizer
      第47回日本神経学会総会
    • Place of Presentation
      東京,京王プラザホテル
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] ジフルニサル,フルフェナム酸,ピコリン酸クロムの血清変異TTR安定化作用の検討2006

    • Author(s)
      東城加奈, 関島良樹, 池田修一
    • Organizer
      第47回日本神経学会総会
    • Place of Presentation
      東京,京王プラザホテル
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] 家族性アミロイドポリニューロパチーの生物学的・化学的発症機序の研究2006

    • Author(s)
      関島良樹, 池田修一, 福嶋 義光
    • Organizer
      第51回日本人類遺伝学会
    • Place of Presentation
      米子,米子コンベンションセンター
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Development of a new therapeuticmethod tor familial amyloidpolyneuropathy using transthyretin tetramer stabilizers2006

    • Author(s)
      Sekiiima, Y., Tojo, K., Kelly, JW., Ikeda, S
    • Organizer
      The 47th Annual Meeting of the Japanese Society of Neurology
    • Place of Presentation
      Tokyo
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] Comparison of serum transthyretin stabilizing effects between diflunisal and flufenamic acid, and trivalent chromium2006

    • Author(s)
      Tojo, K., Sekiiima, Y., Kelly, JW., Ikeda, S
    • Organizer
      The 47th Annual Meeting of the Japanese Society of Neurology, 2006. 5. 11.13
    • Place of Presentation
      Tokyo
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Presentation] The biological and chemical basis for familial amyloid polyneumpathy2006

    • Author(s)
      Sekiiima, Y., Fukushima, Y., Ikeda, S
    • Organizer
      The 51th Annual Meeting of the Japanese Society of Human genetics
    • Place of Presentation
      Yonago
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary

URL: 

Published: 2006-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi